Concentric Wealth Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $4.45M | Buy |
19,904
+104
| +0.5% | +$22.9K | 1.08% | 39 |
|
|
2024
Q2 | $4.03M | Buy |
19,800
+249
| +1% | +$50.7K | 1.05% | 37 |
|
|
2024
Q1 | $4.27M | Buy |
19,551
+448
| +2% | +$98.7K | 1.14% | 35 |
|
|
2023
Q4 | $4.34M | Buy |
19,103
+335
| +2% | +$70.4K | 1.26% | 31 |
|
|
2023
Q3 | $3.77M | Sell |
18,768
-2,821
| -13% | -$595K | 1.24% | 32 |
|
|
2023
Q2 | $4.48M | Buy |
21,589
+72
| +0.3% | +$14K | 1.42% | 24 |
|
|
2023
Q1 | $4.24M | Buy |
21,517
+131
| +0.6% | +$27K | 1.4% | 24 |
|
|
2022
Q4 | $4.33M | Sell |
21,386
-93
| -0.4% | -$18.2K | 1.48% | 22 |
|
|
2022
Q3 | $3.78M | Buy |
21,479
+348
| +2% | +$71.2K | 1.39% | 23 |
|
|
2022
Q2 | $4.25M | Buy |
21,131
+440
| +2% | +$93.8K | 1.44% | 24 |
|
|
2022
Q1 | $4.69M | Sell |
20,691
-176
| -0.8% | -$41.4K | 1.35% | 24 |
|
|
2021
Q4 | $5.63M | Sell |
20,867
-653
| -3% | -$162K | 1.59% | 18 |
|
|
2021
Q3 | $5.2M | Sell |
21,520
-582
| -3% | -$147K | 1.59% | 17 |
|
|
2021
Q2 | $5.24M | Sell |
22,102
-2
| -0% | -$456 | 1.6% | 19 |
|
|
2021
Q1 | $4.84M | Sell |
22,104
-225
| -1% | -$45.2K | 1.6% | 19 |
|
|
2020
Q4 | $3.9M | Sell |
22,329
-250
| -1% | -$43.2K | 1.44% | 26 |
|
|
2020
Q3 | $3.65M | Sell |
22,579
-200
| -0.9% | -$31.7K | 1.57% | 22 |
|
|
2020
Q2 | $3.25M | Buy |
22,779
+98
| +0.4% | +$13.6K | 1.53% | 22 |
|
|
2020
Q1 | $2.46M | Buy |
22,681
+757
| +3% | +$109K | 1.36% | 26 |
|
|
2019
Q4 | $3.19M | Buy |
21,924
+7,438
| +51% | +$1.07M | 1.37% | 27 |
|
|
2019
Q3 | $2.09M | Sell |
14,486
-90
| -0.6% | -$13.1K | 1.33% | 34 |
|
|
2019
Q2 | $2.17M | Sell |
14,576
-5
| -0% | -$698 | 1.41% | 30 |
|
|
2019
Q1 | $1.92M | Buy |
14,581
+1,769
| +14% | +$218K | 1.29% | 32 |
|
|
2018
Q4 | $1.39M | Buy |
12,812
+634
| +5% | +$84.9K | 1.07% | 41 |
|
|
2018
Q3 | $1.82M | Sell |
12,178
-390
| -3% | -$59.3K | 1.27% | 35 |
|
|
2018
Q2 | $1.94M | Buy |
12,568
+606
| +5% | +$91.5K | 1.39% | 31 |
|
|
2018
Q1 | $1.66M | Buy |
11,962
+145
| +1% | +$21.3K | 1.23% | 34 |
|
|
2017
Q4 | $1.62M | Sell |
11,817
-343
| -3% | -$45.3K | 1.17% | 37 |
|
|
2017
Q3 | $1.58M | Buy |
12,160
+203
| +2% | +$27.1K | 1.2% | 38 |
|
|
2017
Q2 | $1.58M | Sell |
11,957
-291
| -2% | -$35.6K | 1.26% | 34 |
|
|
2017
Q1 | $1.51M | Sell |
12,248
-209
| -2% | -$24.7K | 1.23% | 37 |
|
|
2016
Q4 | $1.37M | Buy |
+12,457
| New | +$1.38M | 1.15% | 39 |
|
Other funds holding LH
Concentric Wealth Management's LH Position: Q3 2024 in Review
Concentric Wealth Management increased its Labcorp (LH) stake by 0.53% in Q3 2024, buying an estimated $22.9K and bringing the position to 19,904 shares worth $4.45M. The position accounts for 1.08% of the portfolio, ranked #39.
Concentric Wealth Management first reported a position in LH in Q4 2016 and has held it in 32 quarters since. The position peaked at $5.63M in Q4 2021. 918 funds tracked by Wall St. Rank hold LH as of Q3 2024.
- Concentric Wealth Management held 19,904 shares of Labcorp worth $4.45M as of Q3 2024.
- Concentric Wealth Management bought 104 Labcorp shares in Q3 2024, an estimated $22.9K.
- Labcorp made up 1.08% of Concentric Wealth Management's portfolio in Q3 2024, its #39 holding.
- Concentric Wealth Management first reported a position in Labcorp in Q4 2016 and has held it in 32 quarters since.
- Concentric Wealth Management's Labcorp position peaked at $5.63M in Q4 2021.
- 918 funds tracked by Wall St. Rank held Labcorp as of Q3 2024.
Based on Concentric Wealth Management's 13F filing for Q3 2024, filed 13 Nov 2024.